Caiqin Hu

State Key Laboratory For The Diagnosis And Treatment Of Infectious Diseases
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Safety and Virological Outcomes of a Modified Albuvirtide Intensification Regimen with Standard ART in People with HIV.

Safety and Virological Outcomes of a Modified Albuvirtide Intensification Regimen with Standard ART in People with HIV.

Journal: Infection and drug resistance

Published: April 16, 2026

Two cross-neutralizing antibodies isolated from a COVID-19 convalescent via single B cell sorting.

Two cross-neutralizing antibodies isolated from a COVID-19 convalescent via single B cell sorting.

Journal: Archives of virology

Published: January 20, 2025

Function and structure of broadly neutralizing antibodies against SARS-CoV-2 Omicron variants isolated from prototype strain infected convalescents.

Function and structure of broadly neutralizing antibodies against SARS-CoV-2 Omicron variants isolated from prototype strain infected convalescents.

Journal: Journal of translational medicine

Published: September 13, 2024

Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent.

Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent.

Journal: Pathogens (Basel, Switzerland)

Published: January 28, 2024

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort.

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort.

Journal: Pathogens (Basel, Switzerland)

Published: August 27, 2023

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents.

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents.

Journal: Frontiers in immunology

Published: February 07, 2023

Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China.

Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China.

Journal: Virology journal

Published: July 15, 2022

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.

Journal: Frontiers in cellular and infection microbiology

Published: June 26, 2022

Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations.

Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations.

Journal: Pathogens (Basel, Switzerland)

Published: December 06, 2021

Oral Microbiota Is Associated With Immune Recovery in Human Immunodeficiency Virus-Infected Individuals.

Oral Microbiota Is Associated With Immune Recovery in Human Immunodeficiency Virus-Infected Individuals.

Journal: Frontiers in microbiology

Published: October 14, 2021

Clinical features and Outcomes of Cryptococcemia patients with and without HIV infection.

Clinical features and Outcomes of Cryptococcemia patients with and without HIV infection.

Journal: Mycoses

Published: December 01, 2020

Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.

Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.

Journal: BMC microbiology

Published: July 15, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026